Effect of dapagliflozin in paroxysmal atrial fibrillation combined with heart failure with preserved ejection fraction: a randomized controlled trial

LIAN Xiaoyu; PENG Fei; GONG Hui; QIAN Juying

doi:10.12025/j.issn.1008-6358.2025.20250497

Chinese Journal Of Clinical Medicine, Volume. 32, Issue 3, 342(2025)

Effect of dapagliflozin in paroxysmal atrial fibrillation combined with heart failure with preserved ejection fraction: a randomized controlled trial

LIAN Xiaoyu¹, PENG Fei¹, GONG Hui¹, and QIAN Juying^2、*

Author Affiliations

¹Department of Cardiology, Jinshan Hospital of Fudan University, Shanghai 201508, China

²Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Health Commission Key Laboratory of Ischemic Heart Diseases, Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, National Clinical Research Center for Interventional Medicine, Shanghai 200032, China

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

LIAN Xiaoyu, PENG Fei, GONG Hui, QIAN Juying. Effect of dapagliflozin in paroxysmal atrial fibrillation combined with heart failure with preserved ejection fraction: a randomized controlled trial[J]. Chinese Journal Of Clinical Medicine, 2025, 32(3): 342

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Apr. 23, 2025

Accepted: Aug. 22, 2025

Published Online: Aug. 22, 2025

The Author Email: QIAN Juying (qian.juying@zs-hospital.sh.cn)

DOI:10.12025/j.issn.1008-6358.2025.20250497

Topics